a:head secures pre-Series A funding and appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board

a:head bio AG closed another 7-digit EUR financing round. This funding will further advance the company's mission to bridge the translational gap between preclinical and clinical drug development.

In tandem with the financing, a:head announces the appointment of Margarete Schramboeck, former Austrian Minister of Digital & Economic Affairs, strategic advisor and startup investor, and Madeline Lancaster, founding member of a:head and leading global architect of in-vitro human brain models to its Supervisory Board.

Read the full press release here